FAQ/Help |
Calendar |
Search |
Today's Posts |
03-16-2011, 06:20 PM | #1 | ||
|
|||
Magnate
|
|
||
Reply With Quote |
"Thanks for this!" says: | Conductor71 (03-17-2011) |
03-17-2011, 05:48 AM | #2 | |||
|
||||
Senior Member
|
Quote:
Laura |
|||
Reply With Quote |
03-17-2011, 09:28 AM | #3 | ||
|
|||
Senior Member
|
I too have been watching this one, so glad to hear Phase II went well. It's interesting that the phase II was not at any of the facilities one would expect, like Duke, Vanderbilt, Baylor, etc. Wonder why, anyone know how they choose the sites for these trials?
|
||
Reply With Quote |
03-17-2011, 03:31 PM | #4 | ||
|
|||
Magnate
|
|
||
Reply With Quote |
"Thanks for this!" says: | jeanb (03-21-2011) |
03-22-2011, 01:06 AM | #5 | ||
|
|||
Member
|
" In the Neurologix therapy, an ultra-thin wire is inserted through the skull and passes through brain tissue to reach the subthalamic area. The gene, carried by a harmless virus, journeys into brain cells to ramp up production of the chemical GABA, which limits excess activity to reduce abnormal movements."
PD is charecterised as Dopamine defficiency illness. This new treatment proves to me that PD is much more than that and treatment based on only dopamine enhacement is doomed to failure in the long term. This is IMHO. Imad
__________________
Imad Born in 1943. Diagnosed with PD in 2006. Last edited by imark3000; 03-22-2011 at 01:45 AM. |
||
Reply With Quote |
"Thanks for this!" says: | krugen68 (03-23-2011) |
03-22-2011, 08:39 PM | #6 | ||
|
|||
In Remembrance
|
Quote:
__________________
paula "Time is not neutral for those who have pd or for those who will get it." |
||
Reply With Quote |
"Thanks for this!" says: | krugen68 (03-23-2011) |
03-23-2011, 09:41 AM | #7 | ||
|
|||
Member
|
|
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
pro savin press release | Parkinson's Disease Clinical Trials | |||
B12 Press release.. | Multiple Sclerosis | |||
Brainstorm press release | Parkinson's Disease | |||
FOX Foundation Press Release | Parkinson's Disease | |||
CAMR Press Release | Parkinson's Disease |